Filing Details
- Accession Number:
- 0001209191-22-057947
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-18 17:23:22
- Reporting Period:
- 2022-09-27
- Accepted Time:
- 2022-11-18 17:23:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-27 | 20 | $2.57 | 18,308 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-09-28 | 20 | $2.52 | 18,328 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-09-29 | 20 | $2.51 | 18,348 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-09-30 | 20 | $2.61 | 18,368 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-03 | 20 | $2.54 | 18,388 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-04 | 20 | $2.61 | 18,408 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-05 | 20 | $2.58 | 18,428 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-06 | 20 | $2.65 | 18,448 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-07 | 20 | $2.66 | 18,468 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-10 | 20 | $2.53 | 18,488 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-11 | 20 | $2.48 | 18,508 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-12 | 20 | $2.49 | 18,528 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-13 | 20 | $2.38 | 18,548 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-14 | 20 | $2.31 | 18,568 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-17 | 20 | $2.33 | 18,588 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-18 | 20 | $2.46 | 18,608 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-19 | 20 | $2.42 | 18,628 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-20 | 20 | $2.44 | 18,648 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-21 | 20 | $2.49 | 18,668 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-24 | 20 | $2.38 | 18,688 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-25 | 20 | $2.44 | 18,708 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-26 | 20 | $2.42 | 18,728 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-27 | 20 | $2.49 | 18,748 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-28 | 20 | $2.52 | 18,768 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-10-31 | 20 | $2.54 | 18,788 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Billionaire Hedge Funds
